SCHEMBL17201507

SCHEMBL17201507

CC(C)(C)OC(=O)c1ccc(-c2ccc(F)nn2)s1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.35
KDM4E B2RXH2 4/20 0.33
HPGD P15428 4/20 0.33
NPC1 O15118 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
MAPT P10636 2/20 0.33
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33
RAB9A P51151 4/20 0.32
GAA P10253 1/20 0.32
HDAC6 Q9UBN7 6/20 0.32
HDAC4 P56524 3/20 0.32
HDAC1 Q13547 3/20 0.32
HDAC3 O15379 2/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
ATM Q13315 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
GABRA1 P14867 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17201529 0.80 HDAC6 (0.35) ALDH1A1HPGDCTSSCTSKHDAC6
SCHEMBL8549434 0.75 TSHR (0.44) ALDH1A1HPGDHDAC6HDAC4HDAC1
Trifluoroacetic Acid SCHEMBL17201528 0.74 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDRAB9AGAA
SCHEMBL17201588 0.72 ALDH1A1 (0.36) ALDH1A1KDM4EHPGDMAPTRAB9A
SCHEMBL17201531 0.71 GRM6 (0.35) ALDH1A1HPGDHDAC6HDAC4HDAC1
SCHEMBL14100232 0.70 AAK1 (0.41) ALDH1A1
SCHEMBL17201521 0.70 ALDH1A1 (0.34) ALDH1A1GABRA1GABRG2GABRB3GABRA5
SCHEMBL17201502 0.69 CTSS (0.39) ALDH1A1NPC1SMN1; SMN2CTSSCTSK
SCHEMBL4345360 0.69 DAO (0.53) ALDH1A1KDM4EHPGDNPC1SMN1; SMN2
SCHEMBL8549436 0.69 DAO (0.48) ALDH1A1HPGDRAB9AHDAC6HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9725459-B2 3-oxo-tetrahydro-furo[3,2-B]pyrrol-4(5H)-yl) derivatives I GRUNENTHAL GMBH (DE) 2017-08-08 US disclosed
EP-3140309-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2017-03-15 EP disclosed
WO-2015161928-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 WO disclosed
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I CTSK, OPRK1, CAT ALDH1A1 886/4885KDM4E 997/4885HPGD 614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.